抗B因子抗体与儿童急性感染后肾小球肾炎
本研究回顾性分析34例起病时低C3的儿童急性感染后肾小球肾炎(APIGN),发现91%(31/34)存在抗B因子自身抗体,显著高于低补体C3肾小球病患者的14%(4/28)。抗B因子抗体为一过性,与血浆C3及可溶性C5b-9水平相关,体外实验证实其增强旁路途径转化酶活性,提示其参与APIGN的旁路途径激活。
要点
- 儿童APIGN起病时抗B因子抗体阳性率高达91%,显著高于C3肾小球病的14%。
- 抗B因子抗体为一过性,与血浆C3及sC5b-9水平相关,体外增强旁路途径活性。
- 低C3肾炎综合征起病时筛查抗B因子抗体可能有助于指导肾活检指征。
核心结论
- 抗B因子自身抗体是儿童急性感染后肾小球肾炎旁路补体途径激活的 contributory 因素。
研究设计与样本
- 回顾性研究纳入34例起病时低C3的儿童急性感染后肾小球肾炎患者,并与60例法国国家登记的低补体C3肾小球病患儿对比。
主要发现
- 所有急性感染后肾小球肾炎患儿均存在补体旁路途径激活。
- 起病时抗B因子自身抗体在急性感染后肾小球肾炎患儿中占31/34(91%),在低补体C3肾小球病患儿中占4/28(14%)。
- 急性感染后肾小球肾炎中抗B因子抗体为一过性,与血浆C3和可溶性C5b-9水平相关。
- 体外实验显示抗B因子抗体增强旁路途径转化酶活性,证实其致病作用。
- 研究识别了B因子上的关键抗体结合位点,其中一个与疾病严重程度相关。
临床怎么用
- 对于起病时低C3的肾炎综合征患儿,筛查抗B因子抗体可能有助于指导肾活检指征,避免误诊为C3肾小球病等慢性肾小球病,并辅助治疗决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The pathophysiology of the leading cause of pediatric acute nephritis, acute postinfectious GN, including mechanisms of the pathognomonic transient complement activation, remains uncertain. It shares clinicopathologic features with C3 glomerulopathy, a complement-mediated glomerulopathy that, unlike acute postinfectious GN, has a poor prognosis. METHODS: This retrospective study investigated mechanisms of complement activation in 34 children with acute postinfectious GN and low C3 level at onset. We screened a panel of anticomplement protein autoantibodies, carried out related functional characterization, and compared results with those of 60 children from the National French Registry who had C3 glomerulopathy and persistent hypocomplementemia. RESULTS: All children with acute postinfectious GN had activation of the alternative pathway of the complement system. At onset, autoantibodies targeting factor B (a component of the alternative pathway C3 convertase) were found in a significantly higher proportion of children with the disorder versus children with hypocomplementemic C3 glomerulopathy (31 of 34 [91%] versus 4 of 28 [14%], respectively). In acute postinfectious GN, anti-factor B autoantibodies were transient and correlated with plasma C3 and soluble C5b-9 levels. We demonstrated that anti-factor B antibodies enhance alternative pathway convertase activity in vitro, confirming their pathogenic effect. We also identified crucial antibody binding sites on factor B, including one correlated to disease severity. CONCLUSIONS: These findings elucidate the pathophysiologic mechanisms underlying acute postinfectious GN by identifying anti-factor B autoantibodies as contributing factors in alternative complement pathway activation. At onset of a nephritic syndrome with low C3 level, screening for anti-factor B antibodies might help guide indications for kidney biopsy to avoid misdiagnosed chronic glomerulopathy, such as C3 glomerulopathy, and to help determine therapy.
引用
- Chauvet S, Berthaud R, Devriese M, et al. Anti-Factor B Antibodies and Acute Postinfectious GN in Children. J Am Soc Nephrol. 2020. PMID: 32034108. doi:10.1681/ASN.2019080851
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。